Viewing StudyNCT00074984



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00074984
Status: COMPLETED
Last Update Posted: 2013-12-27
First Post: 2003-12-24

Brief Title: A Study of the Safety and Efficacy of Fabrazyme Agalsidase Beta as Compared to Placebo in Patients With Advanced Fabry Disease
Sponsor: Genzyme a Sanofi Company
Organization: Sanofi

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-02
Start Date Type: None
Primary Completion Date: 2004-01
Primary Completion Date Type: ACTUAL
Completion Date: 2004-01
Completion Date Type: ACTUAL
First Submit Date: 2003-12-24
First Submit QC Date: December 24 2003
Study First Post Date: 2003-12-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2010-12-15
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-12-02
Last Update Post Date: 2013-12-27
Last Update Post Date Type: ESTIMATED